Consuela Albright
Biographic Data
| ID | 8638900 |
|---|---|
| NAME | Consuela Albright |
| GIVEN NAMES | Consuela |
| FAMILY NAME | Albright |
| SIGNATURE | ALBRIGHT C |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Transformed but Not Cured
In December 2023, the U.S. Food and Drug Administration approved gene-editing therapies as sickle cell disease treatments. Such approvals for gene-editing not only mark radical scientific innovations for populations living with sickle cell disease (SCD) across the United States but also generate an expectation of a potential cure-the end or eradication of an illness and its effects. This essay, however, cautions against framing gene-editing thera…
No prominent works on this page.
Transformed but Not Cured
In December 2023, the U.S. Food and Drug Administration approved gene-editing therapies as sickle cell disease treatments. Such approvals for gene-editing not only mark radical scientific innovations for populations living with sickle cell disease (SCD) across the United States but also generate an expectation of a potential cure-the end or eradication of an illness and its effects. This essay, however, cautions against framing gene-editing thera…
Alternative medicine (1 work) · Bioethics (1 work) · Clinical trial (1 work) · CRISPR and Genetic Engineering (1 work) · Disease (1 work) · Food and drug administration (1 work) · Framing (construction) (1 work) · Genome editing (1 work) · Health care (1 work) · Hemoglobinopathy (1 work)